0,950  0,003  Skin irritative effect
0,900  0,004  Eye irritation, high
0,877  0,003  GST A substrate
0,849  0,003  Cholesterol antagonist
0,850  0,009  Antiinflammatory
0,839  0,005  Antihypercholesterolemic
0,835  0,004  Lipoprotein disorders treatment
0,832  0,007  TNF expression inhibitor
0,826  0,004  Platelet antagonist
0,795  0,005  Atherosclerosis treatment
0,772  0,015  Caspase 9 stimulant
0,741  0,009  Carcinogenic
0,724  0,007  Antithrombotic
0,724  0,012  Cyclophilin D inhibitor
0,724  0,012  Antidiabetic
0,714  0,005  Hypolipemic
0,709  0,004  Antihypertriglyceridemic
0,698  0,005  Antidiabetic (type 2)
0,697  0,006  NOS3 expression inhibitor
0,696  0,006  Vasodilator, peripheral
0,673  0,005  Cardioprotectant
0,673  0,005  Antipruritic, allergic
0,669  0,005  Antiglaucomic
0,694  0,032  Apoptosis agonist
0,677  0,018  Teratogen
0,656  0,005  Apoptosis antagonist
0,665  0,018  Embryotoxic
0,652  0,007  Hepatic disorders treatment
0,635  0,005  Platelet aggregation inhibitor
0,638  0,014  Respiratory analeptic
0,628  0,004  Platelet adhesion inhibitor
0,626  0,005  Diabetic retinopathy treatment
0,625  0,005  Vasodilator
0,616  0,003  Antihyperlipoproteinemic
0,633  0,027  Transcription factor NF kappa B inhibitor
0,606  0,004  Acaricide
0,611  0,012  Spasmolytic
0,604  0,008  Hypoglycemic
0,591  0,005  Antidiabetic symptomatic
0,587  0,005  Antiulcerative
0,594  0,014  Mutagenic
0,582  0,004  Mediator release inhibitor
0,587  0,014  Analeptic
0,580  0,008  Tumour necrosis factor alpha release inhibitor
0,571  0,003  GST P1-1 substrate
0,574  0,008  FMO1 substrate
0,575  0,012  Caspase 3 stimulant
0,575  0,012  Antipsoriatic
0,566  0,003  Vanilloid agonist
0,566  0,012  Lipoxygenase inhibitor
0,563  0,019  Antiallergic
0,542  0,010  Angiogenesis stimulant
0,546  0,017  Histamine release inhibitor
0,530  0,008  Myocardial infarction treatment
0,536  0,016  Ulceration
0,536  0,017  GABA C receptor rho-3 antagonist
0,536  0,019  Radioprotector
0,548  0,032  15-Lipoxygenase inhibitor
0,505  0,004  Aldehyde dehydrogenase inhibitor
0,524  0,024  5 Hydroxytryptamine release stimulant
0,506  0,006  Non-steroidal antiinflammatory agent
0,504  0,004  Protein kinase stimulant
0,520  0,020  Immunomodulator
0,511  0,019  UGT1A9 substrate
0,501  0,010  Antihypoxic
0,492  0,004  GST M1-1 substrate
0,486  0,003  Antipruritic, non-allergic
0,491  0,008  Hair growth stimulant
0,485  0,004  Insulin sensitizer
0,493  0,012  UGT2B4 substrate
0,493  0,013  ICAM1 expression inhibitor
0,489  0,013  Vascular (periferal) disease treatment
0,492  0,016  Antipyretic
0,478  0,005  Muscular dystrophy treatment
0,475  0,004  Antieczematic
0,475  0,004  Phospholipase A2 inhibitor
0,478  0,011  Antimutagenic
0,495  0,030  Stroke treatment
0,498  0,034  Immunosuppressant
0,491  0,029  CYP2C19 substrate
0,466  0,004  Tyrosine 3 hydroxylase inhibitor
0,471  0,010  Anesthetic general
0,494  0,034  5 Hydroxytryptamine release inhibitor
0,480  0,022  Antioxidant
0,486  0,031  Immunostimulant
0,469  0,018  Antiparasitic
0,489  0,038  CYP2C9 substrate
0,459  0,008  Abortion inducer
0,441  0,007  VCAM1 expression inhibitor
0,452  0,022  Proliferative diseases treatment
0,433  0,005  Interleukin 4 antagonist
0,451  0,024  NOS2 expression inhibitor
0,429  0,003  Alcohol dehydrogenase substrate
0,451  0,026  Sensitization
0,431  0,009  Phospholipase C inhibitor
0,432  0,012  Septic shock treatment
0,422  0,004  Antihelmintic (Nematodes)
0,418  0,009  UGT2B7 substrate
0,404  0,003  Transcription factor NF kappa B stimulant
0,436  0,035  Antifungal
0,430  0,029  Metabolic disease treatment
0,419  0,022  Radiosensitizer
0,413  0,018  Sedative
0,403  0,009  Skeletal muscle relaxant
0,394  0,010  Lipid peroxidase inhibitor
0,399  0,016  Antihelmintic
0,394  0,016  UGT1A4 substrate
0,408  0,035  Cytotoxic
0,399  0,030  Cardiovascular analeptic
0,390  0,029  Chemopreventive
0,367  0,007  Gastrin inhibitor
0,400  0,040  Antihypertensive
0,374  0,016  Hepatoprotectant
0,377  0,021  RNA-directed DNA polymerase inhibitor
0,360  0,005  Succinate dehydrogenase inhibitor
0,390  0,036  Chemoprotective
0,370  0,016  Antiseptic
0,367  0,014  UGT1A3 substrate
0,391  0,039  CTGF expression inhibitor
0,373  0,023  UDP-glucuronosyltransferase substrate
0,362  0,013  Monophenol monooxygenase inhibitor
0,355  0,007  5-Lipoxygenase inhibitor
0,371  0,024  Interleukin agonist
0,350  0,004  Vanilloid 1 agonist
0,363  0,020  Muscle relaxant
0,358  0,022  Antiparkinsonian, rigidity relieving
0,364  0,027  DNA synthesis inhibitor
0,332  0,004  Toll-Like receptor 2 antagonist
0,374  0,047  12-Lipoxygenase inhibitor
0,373  0,048  Antiischemic
0,340  0,016  Anesthetic
0,351  0,033  UGT1A6 substrate
0,348  0,032  Nitric oxide antagonist
0,328  0,013  Sepsis treatment
0,325  0,011  Acute respiratory distress syndrome (ARDS) treatment
0,319  0,004  Peroxisome proliferator-activated receptor gamma agonist
0,385  0,071  CYP2C19 inhibitor
0,315  0,002  Lysophosphatidic acid 2 receptor antagonist
0,361  0,050  Vasodilator, coronary
0,354  0,044  Interleukin 2 agonist
0,368  0,059  Bone diseases treatment
0,376  0,069  CYP3A4 substrate
0,330  0,024  P-glycoprotein inhibitor
0,339  0,036  Transcription factor STAT3 inhibitor
0,321  0,018  Carcinogenic, group 3
0,307  0,005  Catenin beta inhibitor
0,404  0,103  Antineoplastic (solid tumors)
0,337  0,037  Antineoplastic (liver cancer)
0,303  0,004  Aldehyde dehydrogenase substrate
0,302  0,005  UGT2B10 substrate
0,303  0,007  Adenylate kinase inhibitor
0,382  0,085  Antibacterial
0,310  0,013  Antipruritic
0,351  0,055  Aldehyde oxidase inhibitor
0,309  0,016  Bone formation stimulant
0,305  0,012  Alkylator
0,308  0,016  CYP2B6 inhibitor
0,310  0,019  Urolithiasis treatment
0,305  0,016  Antiparkinsonian, tremor relieving
0,328  0,042  Transcription factor STAT inhibitor
0,298  0,014  Glutathione S-transferase substrate
0,301  0,022  Antiacne
0,381  0,102  Antiarthritic
0,281  0,004  Myasthenia Gravis treatment
0,282  0,005  Calcium antagonist
0,279  0,002  Endocannabinoid uptake inhibitor
0,279  0,003  Arachidonic acid antagonist
0,323  0,047  Antiprotozoal (Leishmania)
0,319  0,044  Flavin-containing monooxygenase substrate
0,336  0,063  AR expression inhibitor
0,288  0,017  Alpha-N-acetylglucosaminidase inhibitor
0,297  0,027  DNA methyltransferase I inhibitor
0,269  0,005  Antirickettsial
0,311  0,049  Free radical scavenger
0,265  0,008  Catalase inhibitor
0,314  0,058  Antineoplastic (multiple myeloma)
0,319  0,063  Antiepileptic
0,264  0,009  Retinoprotector
0,299  0,045  5 Hydroxytryptamine uptake stimulant
0,254  0,005  Photosensitizer
0,266  0,020  Corneal wound healing stimulator
0,271  0,026  Protein-tyrosine phosphatase inhibitor
0,327  0,083  Inflammatory Bowel disease treatment
0,251  0,008  Microtubule formation inhibitor
0,247  0,005  Thioredoxin inhibitor
0,295  0,053  Cytostatic
0,335  0,095  Antiobesity
0,245  0,005  Actinic keratosis treatment
0,250  0,010  UGT2B1 substrate
0,243  0,004  Ornithine decarboxylase inhibitor
0,243  0,004  Oleamide hydrolase inhibitor
0,243  0,004  Adenylate cyclase stimulant
0,239  0,003  Vanilloid 2 antagonist
0,253  0,017  Carcinogenic, group 1
0,251  0,016  Uterine stimulant
0,243  0,009  Antineoplastic, alkylator
0,236  0,003  Acyl-CoA dehydrogenase inhibitor
0,273  0,041  Wound healing agent
0,236  0,005  Toll-Like receptor 2 agonist
0,244  0,015  ATPase inhibitor
0,307  0,078  CYP2D6 substrate
0,234  0,006  TRPA1 agonist
0,231  0,004  Acetyl-CoA transferase inhibitor
0,244  0,018  DNA polymerase I inhibitor
0,232  0,008  Glutamate dehydrogenase inhibitor
0,292  0,069  FMO3 substrate
0,242  0,019  Neuropathy treatment
0,232  0,009  Coagulant
0,255  0,036  Neurotrophic factor enhancer
0,223  0,005  Leukotriene antagonist
0,259  0,043  DNA methylase inhibitor
0,221  0,006  Prolactin inhibitor
0,259  0,044  UGT1A1 substrate
0,215  0,003  Prostaglandin agonist
0,216  0,004  Peroxisome proliferator-activated receptor alpha agonist
0,219  0,011  Potassium channel (Ca-activated) activator
0,283  0,077  CYP1A2 substrate
0,299  0,093  Calcium channel activator
0,214  0,010  Hearing loss treatment
0,262  0,058  Cyclic AMP phosphodiesterase inhibitor
0,207  0,004  Restless leg syndrome treatment
0,227  0,025  Insulin secretagoues
0,286  0,085  Antimycobacterial
0,226  0,025  Anesthetic local
0,229  0,029  Antidote
0,203  0,003  Ca2+-transporting ATPase inhibitor
0,229  0,030  Skin whitener
0,209  0,010  Gastric antisecretory
0,216  0,018  GABA C receptor agonist
0,221  0,023  Cell wall synthesis inhibitor
0,221  0,023  Protein-tyrosine phosphatase 1B inhibitor
0,255  0,060  Interleukin antagonist
0,197  0,002  Lysophosphatidic acid 3 receptor antagonist
0,213  0,019  Antibacterial (Helicobacter pylori)
0,285  0,093  Sodium/bile acid cotransporter inhibitor
0,199  0,007  CDC25A inhibitor
0,227  0,035  Diuretic
0,194  0,003  Antiviral (Parainfluenza)
0,203  0,013  Mucolytic
0,212  0,023  GABA C receptor rho-2 antagonist
0,247  0,058  Anticonvulsant
0,211  0,023  Neurotrophic factor
0,191  0,004  Prostaglandin F2 alpha antagonist
0,267  0,081  Antituberculosic
0,245  0,060  Psychostimulant
0,204  0,020  Expectorant
0,219  0,035  Interferon gamma antagonist
0,206  0,023  Cell adhesion inhibitor
0,184  0,004  Leukotriene B4 antagonist
0,252  0,073  Superoxide dismutase inhibitor
0,213  0,036  Melanin inhibitor
0,261  0,084  Antiosteoporotic
0,187  0,012  Sphingomyelinase inhibitor
0,183  0,008  GST T1-1 substrate
0,254  0,080  Amyotrophic lateral sclerosis treatment
0,210  0,038  Cystic fibrosis treatment
0,180  0,010  Toll-Like receptor 4 antagonist
0,178  0,008  Anabolic
0,177  0,007  UGT2B11 substrate
0,181  0,013  Phosphofructokinase-1 inhibitor
0,202  0,034  Genotoxic
0,176  0,008  Alcohol oxidase inhibitor
0,194  0,028  Cholesterol synthesis inhibitor
0,255  0,090  Antineoplastic (pancreatic cancer)
0,213  0,051  Macular degeneration treatment
0,167  0,007  Glycine transporter 2 inhibitor
0,185  0,025  Cyclooxygenase 3 inhibitor
0,192  0,032  Raynaud's phenomenon treatment
0,176  0,016  Sphingosine 1-phosphate receptor 4 antagonist
0,185  0,027  Farnesoid X receptor antagonist
0,177  0,019  Contraceptive female
0,162  0,004  Thromboxane synthase inhibitor
0,202  0,044  Amylase inhibitor
0,173  0,016  Caspase 3 inhibitor
0,165  0,010  Acetylcholine release stimulant
0,174  0,020  GABA C receptor antagonist
0,228  0,074  Antihypotensive
0,161  0,010  Antiviral (Rhinovirus)
0,177  0,026  Sphingosine 1-phosphate receptor 5 antagonist
0,173  0,024  Choleretic
0,189  0,041  Pancreatic disorders treatment
0,170  0,023  Gastritis treatment
0,194  0,047  Toxic, respiratory center
0,168  0,022  Sphingosine 1-phosphate receptor 2 antagonist
0,172  0,027  Retinopathy treatment
0,202  0,057  Antiviral (Ebola)
0,162  0,017  GABA C receptor rho-1 antagonist
0,173  0,028  Antiviral (Poxvirus)
0,152  0,009  Leukotriene synthesis inhibitor
0,151  0,007  Antidote, heavy metal
0,147  0,005  Thromboxane antagonist
0,153  0,012  Antimetabolite
0,146  0,004  Aconitate hydratase inhibitor
0,149  0,010  Amidase inhibitor
0,148  0,010  Prostaglandin EP2 antagonist
0,230  0,093  DNA damaging
0,168  0,031  Antineoplastic antimetabolite
0,145  0,011  Interferon agonist
0,147  0,013  Lanosterol 14 alpha demethylase inhibitor
0,157  0,024  Antiviral (Influenza B)
0,137  0,004  Thromboxane A2 antagonist
0,182  0,050  UGT2B9 substrate
0,166  0,034  Cystathionine beta-synthase inhibitor
0,144  0,012  Antiprotozoal activity enhancer
0,135  0,004  Acetyl-CoA transferase 1 inhibitor
0,163  0,033  Aminopeptidase B inhibitor
0,140  0,011  Sphingosine 1-phosphate receptor 4 agonist
0,139  0,010  ATPase (Vacuolar H+) inhibitor
0,135  0,008  CDC25B inhibitor
0,171  0,045  Antifungal enhancer
0,211  0,086  Cardiodepressant
0,146  0,021  Triose-phosphate isomerase inhibitor
0,235  0,111  Insulysin inhibitor
0,152  0,028  Carbonic anhydrase III inhibitor
0,226  0,104  Huntington's disease treatment
0,132  0,010  Glycine receptor agonist
0,135  0,013  Potassium channel large-conductance Ca-activated activator
0,124  0,003  Leukotriene C antagonist
0,145  0,025  Arylamine N-Acetyltransferase substrate
0,124  0,004  Anesthetic inhalation
0,155  0,036  Ferrochelatase inhibitor
0,138  0,020  Paget's disease treatment
0,122  0,004  Exportin-1 inhibitor
0,147  0,030  AMP-activated protein kinase stimulant
0,147  0,030  UDP-glucose 4-epimerase inhibitor
0,185  0,068  LDLR expression enhancer
0,128  0,012  Granulocyte macrophage colony stimulating factor agonist
0,163  0,047  Toll-Like receptor antagonist
0,150  0,036  GABA receptor agonist
0,181  0,067  Growth hormone agonist
0,139  0,025  Topoisomerase II alpha inhibitor
0,180  0,067  Tumour necrosis factor antagonist
0,165  0,054  Antidiabetic (type 1)
0,190  0,081  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,116  0,006  Glutamate (mGluR6) antagonist
0,113  0,004  Retinoid X receptor agonist
0,253  0,145  Toll-Like receptor agonist
0,126  0,018  Glutamate release inhibitor
0,139  0,032  Antifungal (Pneumocystis)
0,134  0,027  Antispirochetal
0,110  0,004  Prostaglandin E2 agonist
0,108  0,001  Lysophosphatidic acid receptor 3 agonist
0,118  0,012  Elastase 1 inhibitor
0,114  0,008  Interferon inducer
0,202  0,097  Antineoplastic (lymphocytic leukemia)
0,188  0,083  Antiarrhythmic
0,114  0,009  Antiviral (Herpesvirus 3, Human)
0,110  0,005  Nitric oxide donor
0,124  0,020  Keratolytic
0,179  0,075  Diabetic nephropathy treatment
0,120  0,016  Carbamoyl phosphate synthetase inhibitor
0,105  0,002  Lysophosphatidic acid receptor 1 agonist
0,114  0,011  Protease 3C (Human rhinovirus) inhibitor
0,160  0,057  Hemostatic
0,113  0,009  Vanilloid 4 agonist
0,111  0,008  Fatty acid synthase inhibitor
0,117  0,015  Cannabinoid CB1 receptor agonist
0,124  0,022  Cell adhesion molecule inhibitor
0,162  0,061  Cyclooxygenase inhibitor
0,122  0,021  Glutathione S-transferase inhibitor
0,175  0,076  Lipocortins synthesis antagonist
0,103  0,005  Glucose-6-phosphate isomerase inhibitor
0,111  0,014  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,115  0,017  Antiviral (Hepatitis A)
0,141  0,044  Menstruation disorders treatment
0,165  0,069  Interleukin 6 antagonist
0,123  0,028  Carbonic anhydrase VI inhibitor
0,151  0,057  Antifungal (Cryptococcus)
0,122  0,029  Carbonic anhydrase XIII inhibitor
0,143  0,050  Proteasome inhibitor
0,105  0,013  Peroxisome proliferator-activated receptor gamma antagonist
0,129  0,037  Electron transport complex I inhibitor
0,094  0,003  Leukotriene C4 antagonist
0,163  0,074  Neurotensin receptor agonist
0,210  0,121  Antineurogenic pain
0,103  0,014  Cannabinoid CB2 receptor antagonist
0,094  0,005  Retinoid X alpha receptor agonist
0,112  0,024  Glutamate decarboxylase inhibitor
0,154  0,066  UGT2B15 substrate
0,106  0,018  Estrogen-related receptor beta agonist
0,108  0,021  Epoxide hydrolase inhibitor
0,114  0,028  Interleukin 5 antagonist
0,089  0,003  Prostaglandin D2 agonist
0,109  0,024  Na+ K+ transporting ATPase inhibitor
0,087  0,002  Prostaglandin F2 alpha agonist
0,137  0,052  Antiprotozoal (Amoeba)
0,112  0,028  Antileprosy
0,179  0,095  VEGF expression inhibitor
0,140  0,057  Antihemorrhagic
0,149  0,066  Antianemic
0,087  0,005  Membrane dipeptidase inhibitor
0,155  0,075  Antiviral (Herpes)
0,129  0,049  Carcinogenic, group 2B
0,098  0,019  Anticholelithogenic
0,104  0,025  Lipase inhibitor
0,198  0,120  Antiviral (West Nile virus)
0,101  0,024  Calcium channel L-type blocker
0,123  0,046  Neutropenia treatment
0,086  0,010  Lipocortins synthesis agonist
0,082  0,006  Pregnane X receptor antagonist
0,094  0,018  Phospholipase D inhibitor
0,139  0,064  Cyclooxygenase 1 inhibitor
0,154  0,079  Thrombolytic
0,079  0,005  Peroxisome proliferator-activated receptor alpha antagonist
0,144  0,072  SULT1A3 substrate
0,231  0,159  Antineoplastic (breast cancer)
0,146  0,075  Antiischemic, cerebral
0,105  0,034  Tocolytic
0,139  0,068  Calcium channel blocker
0,112  0,041  Tourette's syndrome treatment
0,078  0,008  Peroxisome proliferator-activated receptor delta agonist
0,113  0,043  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,078  0,008  Squalene synthetase inhibitor
0,231  0,163  Calpain 2 inhibitor
0,072  0,003  Lysophosphatidic acid 1 receptor antagonist
0,088  0,020  Uterine relaxant
0,071  0,004  Prostacyclin agonist
0,097  0,030  Cannabinoid receptor antagonist
0,146  0,079  Movement disorders treatment
0,095  0,029  Selectin antagonist
0,120  0,055  Sphingosine 1-phosphate receptor 2 agonist
0,099  0,033  Glycine receptor antagonist
0,085  0,019  Antimycoplasmal
0,067  0,002  Carbonic anhydrase X inhibitor
0,067  0,002  Carbonic anhydrase VIII inhibitor
0,086  0,021  Gaucher disease treatment
0,142  0,078  Thiol protease inhibitor
0,068  0,004  Prostaglandin EP4 agonist
0,104  0,041  Bile acid receptor antagonist
0,071  0,007  Leukotriene D4 antagonist
0,074  0,012  Adenosine deaminase inhibitor
0,111  0,048  Folate antagonist
0,065  0,003  Elastase 2B inhibitor
0,065  0,003  Elastase 3B inhibitor
0,065  0,003  Elastase 3A inhibitor
0,066  0,004  Prostaglandin EP2 agonist
0,118  0,056  Excitatory amino acid transporter EAAC1 inhibitor
0,085  0,023  Cannabinoid CB1 receptor antagonist
0,075  0,014  Acetyl-CoA transferase 2 inhibitor
0,085  0,024  Potassium channel (Tandem pore domain) blocker
0,238  0,178  CYP2C9 inhibitor
0,062  0,003  Calcium-independent phospholipase A2 inhibitor
0,189  0,130  Cardiotonic
0,069  0,011  Cholesterol esterase inhibitor
0,103  0,046  Antifungal (Candida)
0,080  0,023  Prostaglandin antagonist
0,101  0,044  Antidote, mercury
0,081  0,024  Ribonucleoside-diphosphate reductase inhibitor
0,210  0,155  Antineoplastic (brain cancer)
0,081  0,026  Ribonucleotide reductase inhibitor
0,098  0,043  ErbB-3 antagonist
0,064  0,009  GABA uptake inhibitor
0,092  0,038  Thioredoxin reductase inhibitor
0,059  0,006  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,059  0,007  Kainate receptor agonist
0,167  0,117  Histone acetyltransferase inhibitor
0,077  0,027  TRPA1 antagonist
0,064  0,014  Kainate receptor antagonist
0,054  0,006  Leukotriene B4 receptor 1 antagonist
0,085  0,037  Antidote, organophosphates
0,072  0,024  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,165  0,117  Pneumotoxic
0,072  0,025  Ornithine carbamoyltransferase inhibitor
0,112  0,065  SULT1A1 substrate
0,074  0,027  Transcription factor AP-1 inhibitor
0,115  0,069  Transcription factor STAT6 inhibitor
0,061  0,014  Microtubule stabilization
0,123  0,076  Cyclooxygenase 2 inhibitor
0,086  0,040  GABA aminotransferase inhibitor
0,242  0,197  DNA directed DNA polymerase inhibitor
0,136  0,091  Heat shock protein 70 antagonist
0,070  0,025  Sphingosine 1-phosphate receptor 3 antagonist
0,123  0,078  Antihelmintic (Trematoda)
0,062  0,017  Leukocyte elastase inhibitor
0,133  0,089  Peroxidase inhibitor
0,050  0,008  Vanilloid 3 antagonist
0,167  0,125  Antineoplastic (lymphoma)
0,098  0,057  Interleukin 12 antagonist
0,061  0,020  Squalene epoxidase inhibitor
0,053  0,012  Fumarate hydratase inhibitor
0,142  0,102  Antiviral (Hepatitis C)
0,081  0,042  Histidine decarboxylase inhibitor
0,104  0,065  HDL-cholesterol increasing
0,068  0,029  Potassium channel intermediate-conductance Ca-activated blocker
0,054  0,016  G protein-coupled receptor agonist
0,098  0,061  Electrolyte absorption antagonist
0,081  0,045  Narcotic antagonist
0,178  0,142  Antineoplastic (ovarian cancer)
0,090  0,054  Carcinogenic, group 2A
0,048  0,013  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,097  0,061  Interleukin 1 beta converting enzyme inhibitor
0,045  0,010  HMG CoA reductase inhibitor
0,176  0,140  Calpain inhibitor
0,048  0,014  Prostacyclin antagonist
0,079  0,045  NAT1 substrate
0,039  0,005  Leukotriene B4 receptor 2 antagonist
0,095  0,062  Phosphodiesterase 6D inhibitor
0,065  0,031  Carbonic anhydrase VB inhibitor
0,080  0,047  Porphobilinogen synthase inhibitor
0,131  0,098  Neuropeptide Y1 antagonist
0,072  0,040  Cannabinoid receptor agonist
0,052  0,019  Glutamate (mGluR4) antagonist
0,133  0,100  Hexokinase inhibitor
0,089  0,058  NADH dehydrogenase inhibitor
0,047  0,015  Retinoid X receptor antagonist
0,053  0,022  Cytokine production stimulant
0,054  0,023  Purinergic P2Y antagonist
0,114  0,084  Cathepsin H inhibitor
0,077  0,048  GABA B receptor agonist
0,084  0,054  Antineoplastic antibiotic
0,033  0,004  Isoleucine-tRNA ligase inhibitor
0,057  0,028  Prolyl endopeptidase inhibitor
0,094  0,066  Creatine kinase inhibitor
0,076  0,047  Cathepsin G inhibitor
0,118  0,090  Antiprotozoal (Trichomonas)
0,109  0,081  Shock treatment
0,036  0,008  Prostaglandin H2 antagonist
0,062  0,035  Argininosuccinate synthase inhibitor
0,057  0,031  Autotaxin inhibitor
0,030  0,003  Thromboxane A2 agonist
0,099  0,073  Antiinfertility, female
0,029  0,003  Thromboxane agonist
0,030  0,004  Calcium-dependent phospholipase A2 inhibitor
0,049  0,024  Geranyltranstransferase inhibitor
0,146  0,121  Antiviral (Hepatitis)
0,066  0,041  Antiemphysemic
0,168  0,143  5 Hydroxytryptamine 3E antagonist
0,044  0,019  Kainate receptor 2 antagonist
0,050  0,026  Benzodiazepine antagonist
0,039  0,016  Retinoid X alpha receptor antagonist
0,068  0,046  Acetylcholine M5 receptor agonist
0,039  0,017  Sodium-dependent vitamin C transporter 2 inhibitor
0,131  0,109  Pulmonary hypertension treatment
0,048  0,026  Fructose-1,6-bisphosphatase inhibitor
0,027  0,005  G-protein-coupled receptor 120 agonist
0,074  0,052  Antibiotic
0,124  0,102  Antiprotozoal (Coccidial)
0,171  0,149  Nitric-oxide synthase stimulant
0,049  0,027  Adenylate cyclase 1 inhibitor
0,163  0,142  Antineoplastic (renal cancer)
0,034  0,013  Prostaglandin EP4 antagonist
0,058  0,038  Beta 1 adrenoreceptor antagonist
0,096  0,077  Antiprotozoal (Toxoplasma)
0,057  0,037  Maillard reaction inhibitor
0,024  0,005  Vitamin D receptor agonist
0,023  0,004  Carbonic anhydrase XI inhibitor
0,025  0,006  Toll-Like receptor 8 agonist
0,063  0,045  Hyperparathyroidism treatment
0,158  0,140  Antineoplastic enhancer
0,106  0,088  Growth stimulant
0,070  0,053  Aminopeptidase I inhibitor
0,025  0,008  Retinoid X beta receptor antagonist
0,104  0,088  Antiviral (Hepatitis B)
0,047  0,031  Antiviral (Enterovirus)
0,032  0,016  Hypoxanthine phosphoribosyltransferase inhibitor
0,049  0,034  Carbonic anhydrase XIV inhibitor
0,027  0,011  Elastase 2 inhibitor
0,027  0,011  Elastase 2A inhibitor
0,019  0,004  Calcineurin inhibitor
0,029  0,013  Toll-Like receptor 4 agonist
0,028  0,013  Purinergic P2Y12 antagonist
0,050  0,035  CD45 antagonist
0,044  0,029  Glutamate (mGluR group III) antagonist
0,039  0,024  Glutamate (mGluR8) agonist
0,058  0,043  Biliverdin reductase inhibitor
0,058  0,043  Sphingosine kinase inhibitor
0,160  0,146  Acute neurologic disorders treatment
0,038  0,025  Factor XIIIa inhibitor
0,027  0,014  Vanilloid 2 agonist
0,032  0,019  Prostaglandin EP3 antagonist
0,032  0,021  Methionyl aminopeptidase 1 inhibitor
0,185  0,175  Thyroid hormone antagonist
0,054  0,043  Sphingosine 1-phosphate receptor 1 antagonist
0,110  0,100  Antiviral (Papilloma)
0,035  0,026  Nicotinic acid receptor agonist
0,035  0,026  Inosine monophosphate dehydrogenase inhibitor
0,050  0,041  Cannabinoid CB2 receptor agonist
0,097  0,088  Calcium channel (voltage-sensitive) blocker
0,052  0,044  Glucosylceramidase inhibitor
0,150  0,142  Growth factor agonist
0,046  0,039  HCV NS3/NS4A protease inhibitor
0,041  0,033  GABA B receptor antagonist
0,026  0,018  Thyroid hormone agonist
0,050  0,043  Alpha-mannosidase inhibitor
0,086  0,079  Xanthine oxidase inhibitor
0,079  0,072  mTOR complex 2 inhibitor
0,040  0,033  Angiotensin AT1 receptor antagonist
0,180  0,174  Thyroid hormone beta antagonist
0,060  0,055  Beta adrenoreceptor antagonist
0,021  0,016  Neuraminidase (Influenza B) inhibitor
0,126  0,122  Myocardial ischemia treatment
0,057  0,054  Caspase 9 inhibitor
0,017  0,015  Methylmalonyl-CoA mutase inhibitor
0,081  0,078  Alcohol dehydrogenase inhibitor
0,030  0,027  Calcitonin receptor agonist
0,032  0,030  Arginase inhibitor
0,030  0,027  GABA transporter 3 inhibitor
0,027  0,026  Acetylcholine M4 receptor agonist
0,014  0,013  Purinergic P2Y1 agonist
0,214  0,214  Transcription factor inhibitor
0,010  0,010  Immunosuppressant Cyclosporine-like

